Vincere Biosciences is a Cambridge, MA, company developing disease-modifying therapies for Parkinson's disease. Vincere is founded on a pipeline of molecular targets representing critical pathophysiological nodes of Parkinson's disease. These human genetics- and biology-informed targets have emerged from its parent company, NeuroInitiative LLC that has a patented computational discovery platform which continues to aid and accelerate Vincere's efforts. While the team is intentionally small, we do periodically have openings for amazing candidates. If you want to talk, please send a biosketch to: recruiting@vincerebio.com



Current Openings